A drug called lecanemab that has been shown to slow early stages of Alzheimer’s disease has been conditionally approved by Health Canada, but there are still questions about its availability.

A phase 2 clinical trial published in the Journal of Alzheimer’s Disease suggests that low-dose THC-CBD extract may improve ...

If approved by voters, the $3 billion investment could spark groundbreaking discoveries in Texas labs and reshape how the ...

A study found that poor sleep can negatively impact how well the brain flushes out toxins, increasing the risk of dementia.

Millions of Americans with Alzheimers disease and their caregivers feel the real effects of an issue known as 'sundowning.' ...

Hundreds of people will gather Saturday at The Maryland Zoo in Baltimore to take part in the "Walk to End Alzheimer's." ...

A dad who was diagnosed with younger onset dementia has given a major update to his health, and it’s nothing short of ...

A study done at Monash University showed that the risk of dementia was lowered by 39% when older adults frequently listened ...

• Joan Oliver is the former Northwest Herald assistant news editor. She has been associated with the Northwest Herald since ...

Scientists have identified hundreds of genes that may increase the risk of developing Alzheimer's disease but the roles these genes play in the brain are poorly understood.

Perivascular space volume did not predict dementia. Higher DTI-ALPS (HR 0.866, 95% CI 0.797-0.942, P =0.001) was associated with a lower risk of incident dementia. Higher choroid plexus volume (HR ...